Reference
Toyokawa G, et al. Secondary mutations at I1171 in the ALK gene confer resistance to both Crizotinib and Alectinib. Journal of Thoracic Oncology 9: e86-7, No. 12, Dec 2014. Available from: URL: http://doi.org/10.1097/JTO.0000000000000358 - Japan
Rights and permissions
About this article
Cite this article
Alectinib/crizotinib. Reactions Weekly 1579, 27 (2015). https://doi.org/10.1007/s40278-015-10988-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-10988-4